When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XBIT - XBiotech's bermekimab shows positive effect dermatitis pilot study; shares up 28% premarket
XBiotech Inc.
Thinly traded micro cap XBiotech (NASDAQ:XBIT) is up 28% premarket on light volume in apparent response to preliminary data from an open-label pilot study evaluating IL-1 alpha inhibitor bermekimab in patients with atopic dermatitis (AD).
More news on: Xbiotech, Healthcare stocks news, Stocks on the move,